Eli Lilly Blocks Teva From Selling Generic Alimta
An Indiana federal judge on Monday upheld the validity of Eli Lilly & Co.'s patent for administering its blockbuster cancer treatment drug Alimta, finding that Teva Parenteral Medicines Inc.'s application for...To view the full article, register now.
Already a subscriber? Click here to view full article